Literature DB >> 6218610

[Effect of celiprolol, fenoterol and aminophylline on respiratory tract obstruction during an asthma attack].

H Matthys.   

Abstract

Selective beta 1-blocking drugs without bronchoconstrictor effect are desirable in patients with bronchial asthma and systemic hypertension or tachycardia. Therefore, 15 patients with bronchial asthma were given a single dose of 100 mg celiprolol (and 5 of them 300 mg) and airway obstruction (Raw, FEV1), pulse rate and blood pressure were documented for 3 hours. After 2 hours an additional infusion of aminophylline and after 3 hours an additional inhalation of fenoterol were given. Within 120 minutes after the intake of celiprolol no statistical changes in the measured data (Raw, FEV1, blood pressure and pulse rate) were found. The same was true after the infusion of aminophylline. Reversibility of airway obstruction by fenoterol was better after celiprolol plus aminophylline than without this premedication (p less than 0.05). It is concluded that the beta 1-antagonist celiprolol does not induce relevant airway obstruction in patients with bronchial asthma, and that an additional infusion of aminophylline enhances the bronchodilatory effect of the beta 2-agonist fenoterol (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218610

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

1.  Hemodynamic effects of celiprolol at rest and during exercise; a comparison with enalapril.

Authors:  S Ghiringhelli; E Cozzi; D Tsialtas
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

2.  Comparison of the cardiovascular and pulmonary effects of oral celiprolol, propranolol and placebo in normal volunteers.

Authors:  C M Busst; A Bush
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 3.  Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.

Authors:  J G Riddell; R G Shanks; R N Brogden
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.